Patient Compliance with Medications

Dr. Jack E. Fincham is a graduate of the University of Nebraska College of Pharmacy and was a Kellogg Pharmaceutical Clinical Scientist Fellow at the University of Minnesota where he obtained his PhD in Social and Administrative Pharmacy. Dr. Fincham has completed a Post Graduate Certificate Degree in Health Economics at the University of Aberdeen, Scotland. Dr. Fincham has held academic, research, and administrative positions at several Schools and Colleges of Pharmacy. He has researched varying topics pertaining to patient compliance, medication management, the Medicare drug benefit, smoking cessation, and health economics. Dr. Fincham currently serves as the A. W. Jowdy Professor of Pharmacy Care at the UGA College of Pharmacy and Professor of Public Health in the UGA College of Public Health. He is a member of the University of Georgia Teaching Academy. From 1994 to 2004, Dr. Fincham served as dean of the University of Kansas School of Pharmacy. Dr. Fincham has authored over 200 refereed and professional manuscripts published in sixty journals. He has made over 200 professional and research presentations to allied health, dental, medical, information technology, nursing, nutrition, pharmacy, and public health professional groups from Vietnam, China, Asia, Australia, Canada, Europe, the United Kingdom, and the United States. He has edited and written ten books. Dr. Fincham is the founding editor of the Journal of Public Health Pharmacy and serves as the associate editor of the American Journal of Pharmaceutical Education. Dr. Fincham authored Taking Your Medicine: A Guide to Medication Regimens and Compliance for Patients and Caregivers, published by The Haworth Press (www.takingyourmedicine.com). This book has been listed as one of the “Best consumer health books of 2005” by Library Journal. He has recently completed the book: The Medicare Part D Program: Making the Most of the Benefit, published by Jones & Bartlett Publishers. Dr. Fincham is an active member of numerous pharmacy, public health, and academic associations. He currently serves as a member of the Nonprescription Drug Advisory Committee of the U.S. Food and Drug Administration and has served as an advisor for the CMS Medicare Drug Benefit Program from 2003 until 2007. Dr. Fincham is a Fellow in the American Society of Consultant Pharmacists, a member of Phi Beta Delta Honor Society for International Scholars, Phi Kappa Phi Honor Society, the Rho Chi Pharmaceutical Honor Society, and the Phi Lambda Sigma Pharmacy Leadership Society. In 1997, he was named the recipient of the Faculty Excellence in Pharmacy Administration Award by the National Community Pharmacists Association. Also in 1997, he was given the Dean’s Award for Sustained Contributions to Community Pharmacy Practice by the American College of Apothecaries. In 1998, he was listed as one of the top fifty most influential pharmacists in the United States by Drug Topics magazine.

• About the Author -- Contributors -- Chapter 1. Introduction -- Chapter 2. Scope of Noncompliance and Other Issues -- Drugs, Pharmacists, and Insurance -- Self-care -- Self-medication -- Patient Compliance Issues -- Noncompliance As an Alternative -- The Consequences of Noncompliance -- Factors Affecting Compliance -- Dosing -- Devices to Aid Patient Compliance -- Communication -- Manufacturers -- Summary -- Chapter 3. Drug Therapies Leading to Noncompliant Activity - Jayashri Sankaranarayanan -- Introduction -- Medication Adherence or Compliance: Definitions, Estimates, Measurement, and Interventions -- Theoretical Aspects -- Structure and Demand of Drug Therapies -- Medical-condition-related Factors -- Medication-therapy-related Factors -- Patient-related Factors -- Health Professional Attributes and Health System Factors -- Conclusions and Future Directions -- Chapter 4. The Costs of Noncompliance -- Introduction -- Asthma -- Cardiovascular and Cerebrovascular Disease -- Diabetes -- Infectious Disease -- Seizures -- The Elderly -- Antipsychotic Therapy -- Transplantation Pharmacotherapy -- Chapter 5. Definitions and Measurement of Compliance -- Definitions of Compliance -- Noncompliance: Negative Connotations -- Measurement of Compliance -- Methods to Detect Compliance -- Physicians’ Estimates of Their Patients’ Compliance 85 Can Physicians Be Noncompliant? -- Chapter 6. Models to Evaluate Patient Compliance - Christopher Cook Health Belief Model -- Theory of Reasoned Action -- Theory of Planned Behavior -- Social Cognitive Theory -- Transtheoretical Model -- Other Models -- Conclusions -- Chapter 7. Methods to Impact Patient Compliance -- Types of Impacts on Compliance -- Specific Ways to Improve Compliance -- Getting into the Habit of Complying -- Other Considerations -- Summary -- Chapter 8. Bridging the Gap Between Provider and Patient Variables: Concordance -- The Concordance Movement in Concept and Action -- Concordance -- Chapter 9. Ethics of Compliance -- Capital Punishment and Assisted Suicide -- Noncompliance As a Patient Prerogative -- Health Insurance Portability and Accountability (HIPPA) Act and Impacts Upon Compliance -- Information Technology -- Questionable, If Not, Unethical Practices -- Pharmaceutical Company Research and Clinical Trials -- Chapter 10. The Role of Health Professionals in Influencing Patient Compliance - Richard Schulz -- Recognize Limitations and Biases -- Make Sense of the Vast and Contradictory Literature -- Commitment to the Development of Best Practices Regarding Medication Adherence -- Recent Trends in Compliance Research -- Summary -- Chapter 11. Disease State Management in Older Persons with Hyperlipidemia - Louis Roller, Jenny Gowan -- Lipid-lowering Agents -- Adherence to Lipid-lowering Therapy -- Scenario -- Identification of Drug Therapy Problems -- Possible Changes in Therapy and Benefits/Problems -- Possible Changes in Therapy -- Chapter 12. Current and Future Considerations -- Achieving Perfection? -- Complicated Considerations -- Physician and Drug Effects -- Questions (Important Factors) to Consider -- Future Considerations with Emerging Drug Therapies -- Where Do We Go from Here? -- Index.